Dr. Doris Taylor, CEO Organamet Bio Inc., is developing a groundbreaking way to engineer personalized hearts using a patient's own stem cells. She is a member of the Leadership Advisory Council of BioFabUSA, a Manufacturing USA institute.

President Biden unveiled a plan to expand biomanufacturing, and biotechnology with $2 billion pledged for a variety of efforts last week. Some of these initiatives may have special appeal to North Carolina’s growing life science sector.

Nearly 800 life sciences companies employ some 70,000 people in the state, according to the N.C. Biotechnology...

Some of the images from the first weeks of the COVID-19 pandemic are indelible: doctors and nurses wearing garbage bags instead of gowns and reusing the same protective mask for days at a time; homemade plastic face shields replacing professional-grade models; live coverage of deliveries of personal protective equipment to hard-hit hospitals. The...

Good science does not equate to workable manufacturing. This has been a longstanding truth in tissue engineering, a field that has been in limbo between academic R&D and commercialization for its entire decades-long existence. Now, the U.S. can thank Tom Bollenbach—a Ph.D. in biochemistry who lived that experience for nearly 10 years—for helping to...

Dean Kamen, executive director of the Advanced Regenerative Manufacturing Institute (ARMI), president of Deka Research & Development Corp., and long-time inventor, entrepreneur and advocate for science, is on a new mission to solve the medical industry’s next big problem.

“Your next job is to create all the baseline engineering necessary to create...